Where Pharmacy Strategy Meets Performance
Axis Strategies is a national, operator-led consulting firm that partners with healthcare organizations to transform pharmacy into a high-performing revenue engine. Acting as a fractional executive team, we design, implement, and optimize 340B, specialty, and infusion programs— delivering measurable financial and clinical outcomes, not just recommendations.
Axis leadership has served in executive roles across both for-profit and nonprofit healthcare organizations, including Chief Executive Officer, Chief Pharmacy Officer, and other senior leadership positions. Collectively, they have led complex pharmacy operations generating more than $1 billion in annual revenue across multi-state healthcare systems.
Axis combines executive leadership, operational experience, financial discipline, and healthcare-specific strategy to support complex pharmacy environments.
Strengthen compliance, improve program capture, optimize contract pharmacy performance, and prepare for changing manufacturer and reimbursement dynamics.
Provide executive-level guidance for organizational structure, staffing models, workflow improvement, financial oversight, and performance accountability.
Identify missed revenue opportunities across entity-owned pharmacies, contract pharmacies, specialty programs, referral capture, and payor strategy.
Evaluate, develop, and expand infusion and specialty services with a disciplined focus on patient access, compliance, feasibility, and long-term margin.
Provide ongoing executive-level pharmacy advisory support for strategy, operations, program growth, and organizational alignment.
Help healthcare organizations strengthen compliance infrastructure, improve documentation, and prepare for audits, accreditation, and regulatory oversight.
Axis Strategies partners with leadership teams of organizations responsible for pharmacy, 340B programs, infusion services, and specialty drug strategy.
FQHC systems seeking to optimize 340B performance, expand pharmacy utilization, and strengthen long-term program sustainability.
Integrated healthcare organizations developing or optimizing pharmacy, specialty, and infusion services across multiple sites of care.
Public health organizations seeking strategic pharmacy leadership, specialty program growth, and improved patient access to therapy.
Organizations operating complex pharmacy environments requiring operational strategy, governance, and performance improvement.
Executive leaders responsible for pharmacy performance, regulatory compliance, and revenue sustainability.
Boards and executive leadership teams seeking independent strategic guidance for pharmacy, 340B, and infusion program development.
Axis Strategies partners with healthcare leadership teams navigating the growing complexity of pharmacy operations, 340B optimization, infusion expansion, specialty growth, and revenue sustainability.
Our approach is practical, senior-led, and grounded in real operating experience. We help organizations clarify priorities, strengthen performance, and move critical initiatives forward with discipline and strategic focus.
Axis leadership has collectively overseen pharmacy operations exceeding $1 billion in annual revenue across multi-state healthcare systems.
Daniel Long is a pharmacy executive with more than 15 years of experience leading complex pharmacy operations across retail, specialty, and 340B environments. He has served as Chief Pharmacy Officer for large, complex Federally Qualified Health Center systems and has overseen pharmacy programs generating more than $175 million in annual revenue.
Christi Epps is a nationally recognized pharmacy executive with more than 30 years of leadership experience across large-scale pharmacy operations, specialty pharmacy, and 340B strategy. She has served as Chief Pharmacy Officer for large, complex Federally Qualified Health Center organizations and previously led a national pharmacy services organization to more than $1B in annual revenue.
Healthcare organizations are facing rapid changes across pharmacy reimbursement, the 340B program, and specialty drug distribution. Axis works with leadership teams to navigate these changes while protecting both financial sustainability and patient access.
Manufacturer restrictions, policy discussions, and operational complexity are reshaping how covered entities must manage 340B programs. Organizations must balance compliance, pharmacy program performance, and long-term program sustainability.
For many healthcare organizations, pharmacy programs are critical to financial sustainability. Low utilization, referral leakage, and underperforming pharmacy programs can create major revenue gaps.
Biologic therapies and specialty medications continue to drive healthcare growth. Strategic infusion and specialty program development can improve both patient access and organizational sustainability.
Axis offers a complimentary executive-level assessment to identify opportunities in the following areas:
Complete the form below and an Axis team member will follow up.
Axis partners with healthcare organizations seeking strategic pharmacy leadership, 340B optimization, infusion planning, and revenue growth.
Tell us a little about your organization and what you are exploring.